A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Bob T. Li,Vicky Makker,Darren Buonocore,Michael Offin,Zachary T. Olah,Elizabeth Panora,Ronglai Shen,Alan Loh Ho,Rona Yaeger,Gopa Iyer,Michelle S. Ginsberg,Gary A. Ulaner,David B. Solit,David M. Hyman,Charles M. Rudin,Michael F. Berger,José Baselga,Maurizio Scaltriti,Maria E. Arcila,Mark G. Kris

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

2018

2502Background: Human epidermal growth factor receptor 2 (HER2, ERBB2) amplification occurs in 2-5% of non-breast non-gastric cancers. Ado-trastuzumab emtansine is a HER2 targeted antibody drug con...

Keywords:

Histology
Ado-trastuzumab emtansine
Pathology
Oncology
Internal medicine
Medicine
Human Epidermal Growth Factor Receptor 2
Antibody
in patient
Drug

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations